Total Return chart Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen Other stock markets 19:20:00 06/08/2026 +04			5-day change	1st Jan Change
35.60 ^DKK	+0.28%		-1.39%	-1.66%

07-23	Lundbeck Receives FDA Fast Track Designation for Lu AH69593, Investigational Orexin 2 Receptor Agonist for Narcolepsy	CI
07-23	Lundbeck Secures US FDA Fast Track Designation for Narcolepsy Drug	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.